Abstract |
Matrix metalloproteinases ( MMPs) and the tissue inhibitors of MMPs (TIMPs) have been recognized to play a pivotal role in matrix remodeling following myocardial infarction (MI). The aims of the present study were to examine the expression profile of MMPs/TIMP-1 after MI and to determine whether angiotensin II receptor (ATR) blockade improves MMPs/TIMP-1 balance. Compared with sham-operated rats, in vivo MI-induced a significant elevation of MMP-2, MMP-3 and MMP-9 levels and a marked reduction of TIMP-1 and fibronectin (FN) expressions in infarcted left ventricular free wall (LVFW) and hypertrophic interventricular septum (IS) but not in non-infarcted right ventricle (RV). In addition, regional MI increased MMP-2, MMP-3 and MMP-9, while decreased TIMP-1 and FN in infarcted LVFW and hypertrophic IS compared with the non-infarcted RV. Compared with vehicle-treated MI rats, oral valsartan, but not PD123319, limited infarct size, normalized MMPs/TIMP-1 balance and restored FN level. The present findings might further our understanding of the regulatory mechanisms of valsartan in myocardial remodeling after MI.
|
Authors | Dachun Yang, Shuangtao Ma, De Li, Bing Tang, Yongjian Yang |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 388
Issue 3
Pg. 606-11
(Oct 23 2009)
ISSN: 1090-2104 [Electronic] United States |
PMID | 19695229
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiotensin II Type 1 Receptor Blockers
- Fibronectins
- Imidazoles
- Pyridines
- Receptor, Angiotensin, Type 1
- Tetrazoles
- Tissue Inhibitor of Metalloproteinase-1
- PD 123319
- Valsartan
- Matrix Metalloproteinases
- Valine
|
Topics |
- Angiotensin II Type 1 Receptor Blockers
(pharmacology)
- Animals
- Fibronectins
(biosynthesis)
- Imidazoles
(pharmacology)
- Male
- Matrix Metalloproteinases
(metabolism)
- Myocardial Infarction
(metabolism, pathology)
- Pyridines
(pharmacology)
- Rats
- Rats, Wistar
- Receptor, Angiotensin, Type 1
(drug effects, metabolism)
- Tetrazoles
(pharmacology)
- Tissue Inhibitor of Metalloproteinase-1
(metabolism)
- Valine
(analogs & derivatives, pharmacology)
- Valsartan
|